… We conducted a phase III study comparing BE to E. Methods: Chemotherapy-naïve pts with
… combination with erlotinib (150 mg daily) plus bevacizumab (15 mg/kg iv q3w) or erlotinib (…

… study was the first head-to-head phase III randomised controlled trial comparing erlotinib with
… The results did not support the hypothesis described in the study design, namely, that the …

… There had been no prospective phase III studies directly comparing gefitinib to erlotinib
in the … phase III study to demonstrate the noninferiority of gefitinib compared with erlotinib. …

… In a Phase I study of abemaciclib in patients with advanced NSCLC, those with … study, we
compared abemaciclib to erlotinib, both in combination with best supportive care, in patients …

… improved compared with placebo plus erlotinib 17 and that these results … III METLung
trial (OAM4971g) comparing onartuzumab plus erlotinib with placebo plus erlotinib for patients …

… First, the majority of the patients in phase II clinical trial were at advanced-stages (stage III
or IV), whereas the patients in our study included patients at both early- and advanced- stages. …

… The aim of this study was to assess the efficacy and safety of erlotinib, an … Erlotinib safety
was assessed in all 38 patients in this study, and the AEs observed are summarized in Table III…

… The reported 2-year DFS was 89% in the patients who received … higher percentage of patients
with stage II and III disease in the … During the conduct of our study, two phase III trials were …

… to a phase III study of dacomitinib versus erlotinib in patients with … the PFS in the overall
patient population and in those with wild-… over erlotinib in either of the two patient populations. …

… In this study, we used SEARCH trial,16 erlotinib plus sorafenib as a first-line treatment in
advanced HCC patients had similar OS (p=0.408) and TTP (p=0.18) outcomes compared with …